Clinical Trial Update: A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated whether survodutide (BI-456906) helps adults with overweight or obesity without diabetes lose weight. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Survodutide (BI 456906) (survodutide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Obesity | Phase 3 | Status: COMPLETED